Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SOPHiA GENETICS SA SOPH

Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and... see more

Recent & Breaking News (NDAQ:SOPH)

SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis

Business Wire March 14, 2023

SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results

Business Wire March 7, 2023

University of Arkansas for Medical Sciences Will Use SOPHiA GENETICS to Advance Clinical Research for Blood Cancers

Business Wire March 6, 2023

SOPHiA GENETICS Named to Fast Company's Annual List of the World's Most Innovative Companies for 2023

Business Wire March 3, 2023

SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing

Business Wire March 1, 2023

Synergy Laboratories Taps SOPHiA GENETICS Technology for New Cancer Profiling Solution

Business Wire February 28, 2023

SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023

Business Wire February 23, 2023

SOPHiA GENETICS Expands Partnership With AstraZeneca to Include Multimodal Approaches for Cancer Drug Development

Business Wire February 13, 2023

SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies

Business Wire January 10, 2023

SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference

Business Wire January 4, 2023

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022

GlobeNewswire November 8, 2022

SOPHiA GENETICS to Participate in Upcoming November Investor Conferences

GlobeNewswire November 4, 2022

SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis

PR Newswire November 1, 2022

SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2022 on November 8, 2022

GlobeNewswire October 6, 2022

SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event

GlobeNewswire September 21, 2022

SOPHiA GENETICS to Highlight Innovations and Announcements at Investor Day on September 20, 2022

GlobeNewswire September 20, 2022

SOPHiA GENETICS to Participate in Fireside Chat at 20th Annual Morgan Stanley Global Healthcare Conference

GlobeNewswire September 2, 2022

SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022

GlobeNewswire August 9, 2022

SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City

GlobeNewswire August 4, 2022

SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference

GlobeNewswire July 29, 2022